Trial Profile
Intervention studies with steviol to elucidate dose response relationships and long-term effects in people with type 2 diabetes (Intervention studier med steviol til belysning af dosis respons forhold samt langtidseffekt hos personer med type 2 diabetes)
Status:
Discontinued
Phase of Trial:
Phase I/II
Latest Information Update: 09 Nov 2020
Price :
$35
*
At a glance
- Drugs Isosteviol (Primary)
- Indications Type 2 diabetes mellitus
- Focus First in man; Therapeutic Use
- 08 Nov 2020 Status changed from recruiting to discontinued.
- 10 Dec 2015 New trial record